Skip to main navigation Skip to search Skip to main content

Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)

  • C A Bellera
  • , N Penel
  • , M Ouali
  • , S Bonvalot
  • , PG Casali
  • , OS Nielsen
  • , M Delannes
  • , S Litiere
  • , F Bonnetain
  • , T S Dabakuyo
  • , R S Benjamin
  • , JY Blay
  • , BN Bui
  • , F Collin
  • , T F Delaney
  • , F Duffaud
  • , T Filleron
  • , M Fiore
  • , H Gelderblom
  • , S (Shanti) George
  • R Grimer, P Grosclaude, A Gronchi, R Haas, P Hohenberger, R Issels, A Italiano, V Jooste, A Krarup-Hansen, C Pechoux, C Mussi, O Oberlin, S Patel, S Piperno-Neumann, C Raut, I Ray-Coquard, P Rutkowski, S Schuetze, Stefan Sleijfer, E Stoeckle, M Glabbeke, P Woll, S Gourgou-Bourgade, S Mathoulin-Pelissier
  • External organisation

Research output: Contribution to journalArticleAcademicpeer-review

51 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)865-872
Number of pages8
JournalAnnals of Oncology
Volume26
Issue number5
DOIs
Publication statusPublished - 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research programs

  • EMC MM-03-86-01

Cite this